Pob.Odzoe action
Classification of the incidence of adverse events (WHO):
very often> 1/10
often from> 1/100 to <1/10
infrequently from> 1/1000 to <1/100
rarely from> 1/10000 to <1/1000
very rarely from <1/10000, including individual messages.
From the central and peripheral nervous system:
very often: dizziness;
often: headache;
infrequently: anxiety, confusion, drowsiness;
rarely: euphoria, emotional instability, nightmares, cognitive disorders, hallucinations, amnesia; disorders of coordination of movements, convulsions, paresthesia, tremor, impaired concentration, epileptiform seizures; with prolonged use, it is possible to develop drug dependence; very rarely: panic attacks, ringing in the ears;
From the cardiovascular system:
rarely: tachycardia, palpitations, cardiovascular collapse, fainting,
orthostatic hypotension, cardiovascular failure; very rarely: bradycardia, increased blood pressure;
From the respiratory system:
rarely: dyspnea, respiratory depression, pulmonary edema;
From the sense organs:
very rarely: decreased visual acuity, sometimes mydriasis, a taste disorder;
From the digestive system:
very often: nausea;
often: vomiting, constipation or diarrhea, dryness of the oral mucosa;
infrequently: indigestion, abdominal pain, bloating;
rarely: difficulty swallowing;
very rarely: increased activity of "liver" transaminases;
From the skin:
often: sweating;
From the genitourinary system:
infrequent: urinary retention, increased frequency of urination, menstrual irregularity, signs of menopause;
rarely: dysuria;
From the musculoskeletal system: rarely: muscle weakness;
From the side of metabolism:
infrequently: anorexia;
rarely: weight loss;
Other: with prolonged use - drug dependence; with a sharp abolition - the "cancellation" syndrome.